EMR (EMR) Stock

About EMR

EMR is led by CEO Surendralal Lanca Karsanbhai, employs 73,000 people, headquartered in Saint Louis, US, publicly traded since 1972.

EMR stock trades at $147.68 with a market capitalization of $82.72B. The stock is valued at a price-to-earnings (P/E) ratio of 34.49, price-to-book of 4.34, price-to-sales of 4.76. Over the past 52 weeks the stock has ranged between $122.64 and $166.35, and currently trades 11.2% below its 52-week high. It pays a dividend yielding 1.40%.

On profitability, EMR generates a return on equity (ROE) of 12.69%, above the typical market average, return on capital employed of 11.92%, an operating margin of 19.96%, a net profit margin of 13.83%.

In its most recent fiscal year, EMR reported annual revenue of $18.0B, net profit of $2.3B, revenue has compounded at 1.4% a year over the last five years, profit at 3.1% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.68, a current ratio of 0.88, total assets of $42.0B, $1.5B in cash and equivalents.

EMR has an average daily trading volume of 2,799,118 shares, a beta of 1.24.